Efficacy of second-line chemotherapy after immunotherapy in advanced non-small cell lung cancer

J Thorac Dis. 2023 Jul 31;15(7):3554-3556. doi: 10.21037/jtd-23-858. Epub 2023 Jul 10.

Authors

Tsuyoshi Hirata¹, Taiki Hakozaki^{1

2}

Affiliations

¹ Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
² Graduate School of Advanced Science and Engineering, Faculty of Science and Engineering, Waseda University, Tokyo, Japan.

No abstract available

Keywords: Non-small cell lung cancer (NSCLC); chemotherapy; immune checkpoint inhibitors (ICIs); treatment sequencing.

Publication types

Editorial
Comment